Andrew Whitley was presented with the FACSS Charles Mann Award at SciX 2018, held October 21–26 in Atlanta, Georgia.
Andrew Whitley was presented with the FACSS Charles Mann Award at SciX 2018, held October 21–26 in Atlanta, Georgia.
Andrew Whitley speaking at SciX 2018. (Photo courtesy of Glen P. Jackson.)
The award is presented to an individual who has demonstrated advancements at a conference presented by FACSS in the field of applied Raman Spectroscopy, or who has demonstrated dedication to the advancement of the Raman spectroscopy program at a conference presented by FACSS or the ASTM Raman subcommittee.
Whitley’s career has focused on vibrational spectroscopy and product development and sales. He is the vice president of sales and business development at Horiba Scientific in Piscataway, New Jersey, where he has worked since 2000. In his current role, Whitley is responsible for marketing at Horiba, ensuring important applications and opportunities for product development are identified and properly assessed. His work at Horiba requires networking and collaboration across a wide range of customers and markets to accurately monitor market needs and opportunities.
Whitley received his PhD from the University of Durham in the United Kingdom. His professional memberships include the Society for Applied Spectroscopy, the Coblentz Society, the Royal Society of Chemistry, and the UK Infrared and Raman Discussion Group.
An interview with Whitely is available here.
An Interview with AES Mid-Career Award Recipient Jason Dwyer
July 25th 2024Jason Dwyer of the University of Rhode Island has been named the recipient of the American Electrophoresis Society’s Mid-Career Award, which honors exceptional contributions to the field of electrophoresis, microfluidics, and related areas by an individual who is currently in the middle of their career.
Glucose's Impact on Brain Cancer Cells Unveiled Through Raman Imaging
July 25th 2024Researchers have used Raman spectroscopy and chemometric methods to reveal how glucose affects normal and cancerous brain cell metabolism. Their findings highlight specific biomarkers that can distinguish metabolic changes, potentially aiding in cancer research and treatment.